Correlation Analysis and Diagnostic Value of Serum Homocysteine, Cystatin C and Uric Acid Levels with the Severity of Coronary Artery Stenosis in Patients with Coronary Heart Disease

References

• Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and unhealthful plant-based diets and the risk of coronary heartdisease in U.S. adults. J Am Coll Cardiol. 2017;70(4):411–422. doi:10.1016/j.jacc.2017.05.047
   PubMed Web of Science ®Google Scholar
• Marchenko O, Rudenko NM, Vitomskyi VV, Habida BM. Revisiting the value of haematological and biochemical markers and the ratios in patients with coronary artery disease. Wiad Lek. 2021;74(4):966–972.
   PubMedGoogle Scholar
• Su G, Mi S, Tao H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:19.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen X, Hu X, et al. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 2019;7(1):435.
   Google Scholar
• Kim JY, Choi EY, Mun HS, et al. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. Cardiovasc Diabetol. 2013;12:140.
   PubMed Web of Science ®Google Scholar
• Ayhan SS, Tosun M, Ozturk S, et al. Glycated haemoglobin is correlated with the severity of coronary artery disease independently of traditional risk factors in young patients. Endokrynol Pol. 2012;63(5):367–371.
   PubMed Web of Science ®Google Scholar
• Kręcki R, Krzemińska-Pakuła M, Drożdż J, et al. Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease. Cardiol J. 2010;17(6):599–606.
   PubMed Web of Science ®Google Scholar
• Russo R, Di Iorio B, Di Lullo L, Russo D. Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations. J Nephrol. 2018;31(6):847–853.
   PubMed Web of Science ®Google Scholar
• Rashiti P, Elezi S, Behluli I, Mucaj S. Relationship of plasma adiponectin and waist-hip ratio with coronary artery disease. Med Arch. 2016;70(6):413–418.
   PubMedGoogle Scholar
• Türkoğlu C, Harbalıoğlu H, Şeker T, Baykan AO, Uysal OK. D-dimers are associated with coronary artery disease severity assessed using Syntax and Syntax II scores in patients with ST elevation myocardial infarction. Revista Portuguesa de Cardiologia. 2020;39(12):687–693. doi:10.1016/j.repc.2020.08.006
   PubMed Web of Science ®Google Scholar
• Gao S, Deng Y, Wu J, et al. Eosinophils count in peripheral circulation is associated with coronary artery disease. Atherosclerosis. 2019;286:128–134.
   PubMed Web of Science ®Google Scholar
• Santos JCD, Cruz MS, Bortolin RH, et al. Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions. Clinics. 2018;73:e203.
   PubMed Web of Science ®Google Scholar
• Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P. Correlation of serum homocysteine levels with the severity of coronary artery disease. Indian J Clin Biochem. 2014;9(23):339–344.
   Google Scholar
• Yan L, Ding S, Gu B, Ma P. Clinical application of simultaneous detection of cystatin C, cathepsin S, and IL-1 in classification of coronary artery disease. J Biomed Res. 2017;31(4):315–320.
   PubMedGoogle Scholar
• Tian TT, Li H, Chen SJ, et al. Serum uric acid as an independent risk factor for the presence and severity of early-onset coronary artery disease: a case-control study. Dis Markers. 2018;2018:1236837.
   PubMed Web of Science ®Google Scholar
• Zhou L, Li JJ, Wang KC, Liao XC. The predictive value of cystatin-C and homocysteine for coronary heart disease and stenosis degree. Pract J Clin Med. 2019;16:128–130.
   Google Scholar
• Yao Z, Li G, Li G. Correlation between serum urea nitrogen, cystatin C, homocysteine, and chronic heart failure. Am J Transl Res. 2021;13(4):3254–3261.
   PubMed Web of Science ®Google Scholar
• Hisatome I, Li P, Miake J, et al. Uric acid as a risk factor for chronic kidney disease and cardiovascular disease - Japanese guideline on the management of asymptomatic hyperuricemia. Circ J. 2021;85(2):130–138.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xing C, Hao W, et al. The impact of Sacrubitril/Valsartan on clinical treatment and hs-cTnT and NT-ProBNP serum levels and the left ventricular function in patients with chronic heart failure. Int Heart J. 2020;61(1):1–6.
   PubMed Web of Science ®Google Scholar
• Rampidis GP, Benetos G, Benz DC, Giannopoulos AA, Buechel RR. A guide for Gensini Score calculation. Atherosclerosis. 2019;287:181–183.
   PubMed Web of Science ®Google Scholar
• Fu Z, Yang X, Shen M, et al. Prognostic ability of cystatin C and homocysteine plasma levels for long-term outcomes in very old acute myocardial infarction patients. Clin Interv Aging. 2018;13:1201–1209.
   PubMed Web of Science ®Google Scholar
• Smith AD, Refsum H. Homocysteine - from disease biomarker to disease prevention. J Intern Med. 2021;290(4):826–854.
   PubMed Web of Science ®Google Scholar
• Ma Y, Peng D, Liu C, Huang C, Luo J. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases. BMC Cardiovasc Disord. 2017;17(1):37.
   PubMedGoogle Scholar
• Marković Boras M, Čaušević A, Brizić I, Mikulić I, Vasilj M, Jelić Knezović N. A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. Med Glas (Zenica). 2018;15(2):101–108.
   PubMedGoogle Scholar
• Wang XC, Sun WT, Yu CM, et al. ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IKCa and SKCa channels. Atherosclerosis. 2015;242(1):191–198.
   PubMed Web of Science ®Google Scholar
• Hou HT, Wang J, Zhang X, et al. Endothelial nitric oxide synthase enhancer AVE3085 reverses endothelial dysfunction induced by homocysteine in human internal mammary arteries. Nitric Oxide. 2018;18:21–27.
   Google Scholar
• Muzurović E, Kraljević I, Solak M, Dragnić S, Mikhailidis DP. Homocysteine and diabetes: role in macrovascular and microvascular complications. J Diabetes Complications. 2021;35(3):107834.
   PubMed Web of Science ®Google Scholar
• Yuan S, Mason AM, Carter P, Burgess S, Larsson SC. Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study. BMC Med. 2021;19(1):97.
   PubMed Web of Science ®Google Scholar
• Pang X, Liu J, Zhao J, et al. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells. Atherosclerosis. 2014;236:73–81.
   PubMed Web of Science ®Google Scholar
• Mangge H, Becker K, Fuchs D, Gostner JM. Antioxidants, inflammation and cardiovascular disease. World J Cardiol. 2014;6:462–477.
   PubMedGoogle Scholar
• Okura T, Miyoshi K, Irita J, et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep. 2014;4:5663.
   PubMed Web of Science ®Google Scholar
• de Luis D, Fernandez N, Arranz M, Aller R, Izaola O, Romero E. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications. 2005;19:42–46.
   PubMed Web of Science ®Google Scholar
• Schaffer A, Verdoia M, Barbieri L, Cassetti E, Suryapranata H, De Luca G. Impact of diabetes on homocysteine levels and its relationship with coronary artery disease: a single-centre cohort study. Ann Nutr Metab. 2016;68:180–188.
   PubMed Web of Science ®Google Scholar
• Gevorgyan MM, Voronina NP, Goncharova NV, et al. Cystatin C as a marker of progressing cardiovascular events during coronary heart disease. Bull Exp Biol Med. 2017;62(4):421–424.
   Google Scholar
• Okyay K, Yıldırır A, Çiçek M, Aydınalp A, Müderrisoğlu H. Serum cystatin C and neutrophil gelatinase-associated lipocalin in predicting the severity of coronary artery disease in diabetic patients. Anatol J Cardiol. 2016;16(10):756–761.
   PubMed Web of Science ®Google Scholar
• Hanna D, Beshir M, Khalifa N, Baz E, Elhewala A. Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study. Pediatr Hematol Oncol. 2021;38(7):620–632.
   PubMed Web of Science ®Google Scholar
• Angelidis C, Deftereos S, Giannopoulos G, et al. Cystatin C: an emerging biomarker in cardiovascular disease. Curr Top Med Chem. 2013;13(2):164–178.
   PubMed Web of Science ®Google Scholar
• Wang Y, Su X, Zhang W, Yang W, Wang Y, He Y. Correlation between serum cystatin C level and elderly hypertensive patients combined coronary heart disease. Int J Clin Exp Med. 2015;8(4):6287–6290.
   PubMed Web of Science ®Google Scholar
• West M, Kirby A, Stewart RA, et al. Circulating Cystatin C is an independent risk marker for cardiovascular outcomes, development of renal impairment, and long-term mortality in patients with stable coronary heart disease: the LIPID study. J Am Heart Assoc. 2022;11(5):e020745.
   PubMed Web of Science ®Google Scholar
• Mariani M, Mariani G, De SS. Clinical significance of cystatin C in acute coronary syndromes: is it really more than a marker of renal function? Inflammation Cell Signaling. 2014;1(4):e229.
   Google Scholar
• Sur A, Mishra P, Swain M, Mohapatra N. Study of serum cystatin C, lipid profile and electrolytes in acute stroke patients. Int J Clin Bio Res. 2015;2(4):194–197.
   Google Scholar
• Fabjan T, Penko M, Hojs R. Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients. Ren Fail. 2014;36(1):81–86.
   PubMed Web of Science ®Google Scholar
• Maulana S, Nuraeni A, Aditya Nugraha B. The potential of prognostic biomarkers of uric acid levels in coronary heart disease among aged population: a scoping systematic review of the latest cohort evidence. J Multidiscip Healthc. 2022;15:161–173.
   PubMed Web of Science ®Google Scholar
• Tanındı A, Erkan AF, Alhan A, Töre HF. Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease. Anatol J Cardiol. 2015;15(5):396–403.
   PubMed Web of Science ®Google Scholar
• Mandurino-Mirizzi A, Demarchi A, Ruffinazzi M, et al. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. J Cardiovasc Med. 2020;21(4):337–339.
   Google Scholar
• Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–57.
   PubMed Web of Science ®Google Scholar
• Jeong HY, Cho HJ, Kim SH, et al. Association of serum uric acid level with coronary artery stenosis severity in Korean end-stage renal disease patients. Kidney Res Clin Pract. 2017;36(3):282–289.
   PubMedGoogle Scholar
• Ando K, Takahashi H, Watanabe T, et al. Impact of serum uric acid levels on coronary plaque stability evaluated using integrated backscatter intravascular ultrasound in patients with coronary artery disease. J Atheroscler Thromb. 2016;23(8):932–939.
   PubMed Web of Science ®Google Scholar
• Liang L, Hou X, Bainey KR, et al. The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis. Clin Cardiol. 2019;42(11):1079–1086.
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu X, Jiang L, Mao S, Yin X, Guo L. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord. 2016;16(1):1–10.
   PubMedGoogle Scholar
• Chu X, Lu Y, Mei M, et al. Correlation between serum uric acid levels and coronary plaque characteristics on optical coherence tomography. Int Heart J. 2022;63(5):806–813.
   PubMed Web of Science ®Google Scholar
• Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729–1741.
   PubMed Web of Science ®Google Scholar
• Wang R, Song Y, Yan Y, Ding Z. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis. Atherosclerosis. 2016;254:193–199.
   PubMed Web of Science ®Google Scholar
• Masi S, Pugliese NR, Taddei S. The difficult relationship between uric acid and cardiovascular disease. Eur Heart J. 2019;40(36):3055–3057.
   PubMed Web of Science ®Google Scholar
• Bakhai A, Darius H, De Caterina R, et al. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry. Eur Heart J Qual Care Clin Outcomes. 2016;2:299–305.
   PubMedGoogle Scholar
• Mengozzi A, Pugliese NR, Desideri G, et al. Serum uric acid predicts all-cause and cardiovascular mortality independently of hypertriglyceridemia in cardiometabolic patients without established CV disease: a sub-analysis of the URic acid Right for heArt Health (URRAH) study. Metabolites. 2023;13(2):244.
   PubMed Web of Science ®Google Scholar
• Pugliese NR, Mengozzi A, Virdis A, et al. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk. Clin Res Cardiol. 2021;110(7):1073–1082.
   PubMed Web of Science ®Google Scholar